跳至主要内容
临床试验/ISRCTN12394803
ISRCTN12394803进行中(未招募)未知

Diagnosis and management of febrile illness using RNA personalised molecular signature diagnosis

Imperial College London0 个研究点目标入组 5,000 人开始时间: 2020年6月22日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
5,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. A patient of any age who attends or who is admitted at a participating hospital
  • 2. AND who has one or more of the following;
  • 2.1. Fever (=38.0 °C) or history of fever in the preceding 24 hours
  • 2.2. Symptoms (including non-specific signs) suggestive of infection
  • 2.3. Symptoms suggestive of inflammation (including exacerbation of pre-existing inflammatory disease), and including non-specific signs/symptoms such as fever, joint pains, muscle pains, headaches, lymphadenopathy/fatigue, abdominal pain, rashes, mucosal inflammation, elevated inflammatory markers, unexplained cytopenias
  • 3. AND EITHER who gives consent for samples to be taken for research
  • 4. OR who retrospectively gives consent, according to a deferred consent model in which consent is obtained after initial sample collection

排除标准

  • 1. Patients who do not give consent
  • 2. RNA sample is not taken

研究者

相似试验

DIAMONDS-SEARCH study: Designing new tests that can... | 临床试验